|
In the United States, Hepatitis B Remains a Major Public Health Issue
- 1 out of 20 people have been infected with the hepatitis B virus (HBV)9
- Each year 100,000 new people will become infected with HBV9
- There are more than 1 million chronic carriers of HBV9
- One third of the chronic HBV carriers do not know how they were infected with the disease3
- 5,000 people will die from hepatitis B and its complications every year9
- Infants born to infected mothers are at high risk of developing chronic infection and should receive appropriate medical management13
- 1 in 10 Asian Americans is infected8
Click on the links below to view a short video clip from "Hepatitis B: Facing
the Challenge."
If you would like a copy of the full 7-minute version of this video, please contact GlaxoSmithKline at (888) 825-5249.
The Hepatitis B Video is in WMV format. If you do not have the
Microsoft® Windows Media® Player installed, you can download it for free.

EPIVIR-HBV is indicated for the treatment of chronic hepatitis B associated with viral replication and active liver inflammation in adults and children 2-17 years.
^ | Top
|